Oncology News

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Spring is here, bringing Canadians outside and into a season of movement, renewal, and community action, as Breast Cancer Canada’s Walk-a-Thon to Mother’s Day returns nationwide. Breast Cancer Canada is proud to share its Mother’s Day plans for Sunday, May 10, 2026, as the culmination of its Spring Campaign for Progress. The national initiative unites communities across Canada through a shared commitment to breast cancer research, culminating in the annual...

MIAMI--(BUSINESS WIRE)--Precision IO Group, the parent company of Quantum Surgical, announced the launch of EPIOS, a new U.S. clinical study evaluating the safety and performance of the Epione® robotic platform for the treatment of bone tumors and metastases. The study is designed to support the expansion of Epione’s market approvals in the United States. The first patient was treated on April 28, 2026, in a leading cancer center based in Miami, Florida. Epione has been CE marked for bone indic...

NEW YORK--(BUSINESS WIRE)--The Pershing Square Sohn Cancer Research Alliance, a program of The Pershing Square Foundation, today announced the 13 winners of the 2026 Pershing Square Sohn Cancer Prize, marking a transformative expansion of the program from a regional initiative into a national platform supporting the next generation of cancer researchers. This year, the Alliance doubled the number of Prize recipients after broadening eligibility beyond the New York metropolitan area to instituti...

LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to postpone the commencement of the previously announced tender offer to acquire all outstanding shares of Assertio to May 8, 2026. As previously announced on May 4, 2026, Assertio has entered into an amended and restated merger agreement (the “Garda Agreement”) to be acquired by Garda for $21.80...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the acquisition of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN). “The Terns acquisition reflects Merck’s continued focus on science‑driven, value‑enhancing business development aimed at bringing meaningful innovation to patients,” said Robert M. Davis, chairman and chief executive officer, Merck. “We believe TERN‑701 has the potential to be...

BURLINGAME, Calif.--(BUSINESS WIRE)--The Triton Robotic Endoscopy System from Neptune Medical shows no adverse events and 100% cecal intubation in colonoscopy in its first-in-human study....

TEL AVIV, Israel--(BUSINESS WIRE)--Ibex Medical Analytics, the global leader in clinical-grade AI-powered pathology, today announced the appointment of Ruth March, PhD and Paolo Tarantino, MD, PhD to its newly established Biopharma Advisory Board. Dr. Tarantino and Dr. March are the first members of the Advisory Board, with additional experts expected to join in the coming months. The formation of the Advisory Board reflects Ibex’s strategic expansion into biopharma and its commitment to partne...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced that its CEO and CFO will participate in one-on-one investor meetings at the D. Boral Capital 2026 Global Conference. Hosted by D. Boral Capital, this curated forum at The Plaza Hotel brings together executives from emerg...

MIAMI--(BUSINESS WIRE)--The FedEx/St. Jude Angels and Stars Gala united the Miami and South Florida community, raising a record $1.7 million for St. Jude Research Hospital....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sail Biomedicines Appoints Gene Marcantonio, M.D., Ph.D., as Chief Medical Officer...